Lilly Brings Drug Development to the Classroom With New College Course Offering

INDIANAPOLIS, IN – Graduate students across the country with an interest in health care and medical research will soon have the opportunity to learn about a lesser-known area of patient care — the drug discovery and development process. Eli Lilly and Company (NYSE:LLY) has collaborated with 10 leaders from academic institutions to create an elective graduate level course, “Making Medicines: The Process of Drug Development.”  Lilly formally unveiled the eLearning course at the American Osteopathic Association scientific conference in Orlando, FL, October 17-21, and will launch its pilot program with academic partners beginning in 2016.

The online drug development course provides an interactive platform for students to explore the fundamental principles of drug development, learn about the regulatory environment that govern the biopharmaceutical industry, and identify the roles of key stakeholders, including physicians, who develop, investigate, and regulate biopharmaceutical products. The course includes seven chapters that contain various elements, such as expert videos from the perspective of the FDA and NIH, knowledge checks, case studies and competency tests.

“We identified a knowledge gap surrounding the biopharmaceutical industry and its drug discovery and development process,” says Yolanda Johnson-Moton, director–External Relations Medical Affairs, Lilly USA, “and set out to find a solution that would further education and awareness. Our unified focus is on creating better patient outcomes, and the healthcare providers of tomorrow are an integral part of the process.”

“The ‘Making Medicines: The Process of Drug Development’ course allows students to engage in a self-directed learning process to become familiar with drug discovery and development,” says Dr. Marc Kahn, senior associate dean, Tulane University School of Medicine. “Students will obtain useful knowledge in a self-paced setting and will apply that knowledge in a series of assessment exercises.  I plan to use this course as an elective for senior medical students who want to learn more about drug development, the FDA and the biopharmaceutical industry.”

The launch of the course comes shortly after the introduction of Lilly’s Medical Student Rotation Program, a four-week experiential learning program at their Indianapolis headquarters, where third- and fourth-year medical students familiarize themselves with the biopharmaceutical industry and its role in the practice of medicine through real-world projects and workshops. Future healthcare providers, who will be dependent on new medicines for their patients, will benefit from learning about the discovery and approval process.

“These student programs offer Lilly the opportunity to bring forth its longstanding focus on education and build collaborative relationships,” says Johnson-Moton. “The Making Medicines: The Process of Drug Development” course provides flexibility to fit within existing academic programs. Our goal is reach more students with an interest in medical research and help provide a balanced perspective on the process and rigor behind drug development.”

To learn more, visit: www.making-medicines.com/information

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com.

Featured

  • MiEN Releases White Paper on Community College Space Innovation

    MiEN Company recently released a new white paper called “Designing New Innovative Spaces for Community Colleges” to address the needs of community colleges post-pandemic, according to a news release. The eight-page guide by Dr. Christina Counts, MiEN Company VP of Education and Marketing, covers topics like the enrollment drop that these schools have seen since COVID-19, the roles they play in higher education and local workforces, and five suggested key changes that can improve students’ experiences.

  • New Jersey PreK–12 School Breaks Ground on New STEM Building

    Saddle River Day School (SRDS) in Saddle River, N.J., recently announced that it has broken ground on the new Dr. Kristen Walsh Hall of Science & Entrepreneurship, according to a news release. The school partnered with DIGroup Architecture for the design of the new facility, which will provide the school with space to expand its STEM and business education classes.

  • modern college building with circuit and brain motifs

    Anthropic Introduces Claude for Education

    Anthropic has launched a version of its Claude AI assistant tailored for higher education institutions. Claude for Education "gives academic institutions secure, reliable AI access for their entire community," the company said, to enable colleges and universities to develop and implement AI-enabled approaches across teaching, learning, and administration.

  • Image courtesy of Armstrong International

    The Modern Hot Water System Approach to Keep Higher Education Buildings Safe and Operational

    Higher education campuses face unique structural and operational demands. With a range of old and new buildings, a variety of facility types, and ambitious sustainability goals, it's essential that no aspect of infrastructural performance is overlooked. Facility managers must be equipped to provide a safe, reliable and efficient space for students, faculty and guests.

Digital Edition